GLRX2
Glutaredoxin-2, mitochondrial
Also known as: bA101E13.1, GLRX2_HUMAN, GRX2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NS18
- Gene
- GLRX2
- Ensembl
- ENSG00000023572
- Chromosome
- 1
- Canonical length
- 164 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a member of the glutaredoxin family of proteins, which maintain cellular thiol homeostasis. These proteins are thiol-disulfide oxidoreductases that use a glutathione-binding site and one or two active cysteines in their active site. This gene undergoes alternative splicing to produce multiple isoforms, one of which is ubiquitously expressed and localizes to mitochondria, where it functions in mitochondrial redox homeostasis and is important for the protection against and recovery from oxidative stress. Other isoforms, which have more restrictive expression patterns, show cytosolic and nuclear localization, and are thought to function in cellular differentiation and transformation, possibly with a role in tumor progression. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
164 residues, UniProt reviewed canonical sequence.
>Q9NS18|GLRX2
1 MIWRRAALAG TRLVWSRSGS AGWLDRAAGA AGAAAAAASG MESNTSSSLE NLATAPVNQI
61 QETISDNCVV IFSKTSCSYC TMAKKLFHDM NVNYKVVELD LLEYGNQFQD ALYKMTGERT
121 VPRIFVNGTF IGGATDTHRL HKEGKLLPLV HQCYLKKSKR KEFQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GLRX2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 31 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 31 nTPM
- heart muscle: 30 nTPM
- testis: 27 nTPM
- tongue: 23 nTPM
- liver: 21 nTPM
- cerebral cortex: 20 nTPM
Single-cell type
- late spermatids: 2,934 nCPM
- early spermatids: 1,047 nCPM
- late primary spermatocytes: 137 nCPM
- megakaryocytes: 93 nCPM
- esophageal suprabasal cells: 77 nCPM
- esophageal basal cells: 69 nCPM
Immune cell
- non-classical monocyte: 30 nTPM
- eosinophil: 27 nTPM
- intermediate monocyte: 23 nTPM
- myeloid DC: 23 nTPM
- classical monocyte: 19 nTPM
- T-reg: 19 nTPM
Brain region
- cerebral cortex: 14 nTPM
- hypothalamus: 13 nTPM
- pons: 12 nTPM
- white matter: 11 nTPM
- medulla oblongata: 10 nTPM
- cerebellum: 9.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.62
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.39
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- cell differentiation
- cell redox homeostasis
- DNA protection
- glutathione metabolic process
- regulation of DNA-templated transcription
- regulation of signal transduction
- response to redox state
- response to temperature stimulus
Molecular functions
- 2 iron, 2 sulfur cluster binding
- electron transfer activity
- glutathione disulfide oxidoreductase activity
- metal ion binding
- protein disulfide isomerase activity
- protein-disulfide reductase activity
- arsenate reductase (glutaredoxin) activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GLRX2 as an antibody target. Whether an autoantibody or antibody against GLRX2 could matter depends on whether native GLRX2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GLRX2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GLRX2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...